Compare Revvity Inc (RVTY) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Sana Biotechnology Inc — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Revvity Inc is far larger — about 13.6× Sana Biotechnology Inc's market cap, and Revvity Inc pays a 0.26% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| RVTY | SANA | |
|---|---|---|
Market Cap | $11.87B | $873.84M |
Sector | Technology | Health |
52-Week High | $117.75 | $5.92 |
52-Week Low | $82.26 | $2.68 |
Enterprise Value | $14.36B | $848.03M |
Dividend Yield | 0.26% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
